Dexmedetomidine as an Adjuvant in Peripheral Nerve Block.
Chen Z, Liu Z, Feng C, Jin Y, Zhao X.
Drug Des Devel Ther. 2023 May 17;17:1463-1484. doi: 10.2147/DDDT.S405294. eCollection 2023.
Targeting plasmodium alpha-tubulin-1 to block malaria transmission to mosquitoes.
Zhang G, Niu G, Hooker-Romera D, Shabani S, Ramelow J, Wang X, Butler NS, James AA, Li J.
Front Cell Infect Microbiol. 2023 Mar 16;13:1132647. doi: 10.3389/fcimb.2023.1132647. eCollection 2023.
To block, or not to block is it still the question? Effectiveness of alpha- and beta-blockade in phaeochromocytoma surgery: an institutional analysis.
Van Den Heede K, Paspala A, Chander N, Chidambaram S, Wernig F, Todd JF, DiMarco AN, Palazzo FF.
Ann R Coll Surg Engl. 2022 Feb;104(2):138-143. doi: 10.1308/rcsann.2021.0133. Epub 2021 Sep 28.
Labetalol and other agents that block both alpha- and beta-adrenergic receptors.
Pearce CJ, Wallin JD.
Cleve Clin J Med. 1994 Jan-Feb;61(1):59-69; quiz 80-2. doi: 10.3949/ccjm.61.1.59.
Alpha(4)beta(7)/alpha(4)beta(1) dual integrin antagonists block alpha(4)beta(7)-dependent adhesion under shear flow.
Egger LA, Kidambi U, Cao J, Van Riper G, McCauley E, Mumford RA, Amo S, Lingham R, Lanza T, Lin LS, De Laszlo SE, Young DN, Kopka IE, Tong S, Pikounis B, Benson E, Warwood S, Bargatze RF, Hagmann WK, Schmidt JA, Detmers PA.
J Pharmacol Exp Ther. 2002 Jul;302(1):153-62. doi: 10.1124/jpet.302.1.153.
beta-Amyloid and alpha-synuclein cooperate to block SNARE-dependent vesicle fusion.
Choi BK, Kim JY, Cha MY, Mook-Jung I, Shin YK, Lee NK.
Biochemistry. 2015 Mar 10;54(9):1831-40. doi: 10.1021/acs.biochem.5b00087. Epub 2015 Mar 2.
Inter-block information: to recover or not to recover it?
Möhring J, Williams E, Piepho HP.
Theor Appl Genet. 2015 Aug;128(8):1541-54. doi: 10.1007/s00122-015-2530-0. Epub 2015 May 14.
Block Copolysaccharides from Methylated and Acetylated Cellulose and Starch.
Sommer K, Zollfrank C.
Biomacromolecules. 2022 Jun 13;23(6):2280-2289. doi: 10.1021/acs.biomac.1c01673. Epub 2022 Jun 3.
Interaction between alpha- and beta-adrenoceptor-mediated cardiovascular effects.
van Zwieten PA.
J Cardiovasc Pharmacol. 1986;8 Suppl 4:S21-8. doi: 10.1097/00005344-198608004-00004.
Characteristics of nondepolarizing neuromuscular block: (I) post-junctional block by alpha-bungarotoxin.
Lee C, Chen D, Katz RL.
Can Anaesth Soc J. 1977 Mar;24(2):212-9. doi: 10.1007/BF03006234.
